These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 25422662

  • 1. Anethum graveolens and hyperlipidemia: A randomized clinical trial.
    Mirhosseini M, Baradaran A, Rafieian-Kopaei M.
    J Res Med Sci; 2014 Aug; 19(8):758-61. PubMed ID: 25422662
    [Abstract] [Full Text] [Related]

  • 2. Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients.
    Kojuri J, Vosoughi AR, Akrami M.
    Lipids Health Dis; 2007 Mar 01; 6():5. PubMed ID: 17328819
    [Abstract] [Full Text] [Related]

  • 3. Anethum graveolens L. (Dill) Effect on Human Lipid Profile: An Updated Systematic Review.
    Sadeghi M, Kabiri S, Amerizadeh A, Heshmat-Ghahdarijani K, Masoumi G, Teimouri-Jervekani Z, Amirpour A.
    Curr Probl Cardiol; 2022 Nov 01; 47(11):101072. PubMed ID: 34838903
    [Abstract] [Full Text] [Related]

  • 4. The effects of Anethum graveolens (dill) supplementation on lipid profile and glycemic control: a systematic review and meta-analysis of randomized controlled trials.
    Mousavi SM, Beatriz Pizarro A, Akhgarjand C, Bagheri A, Persad E, Karimi E, Wong A, Jayedi A.
    Crit Rev Food Sci Nutr; 2022 Nov 01; 62(21):5705-5716. PubMed ID: 33624557
    [Abstract] [Full Text] [Related]

  • 5. Lipid Lowering Effects of Hydroalcoholic Extract of Anethum graveolens L. and Dill Tablet in High Cholesterol Fed Hamsters.
    Abbasi Oshaghi E, Khodadadi I, Saidijam M, Yadegarazari R, Shabab N, Tavilani H, Goodarzi MT.
    Cholesterol; 2015 Nov 01; 2015():958560. PubMed ID: 26823981
    [Abstract] [Full Text] [Related]

  • 6. Hypolipidemic activity of Anethum graveolens in rats.
    Hajhashemi V, Abbasi N.
    Phytother Res; 2008 Mar 01; 22(3):372-5. PubMed ID: 18058989
    [Abstract] [Full Text] [Related]

  • 7. Favorable effects of Anethum graveolens on liver oxidative stress and cholesterol 7 alpha-hydroxylase levels in non-alcoholic fatty liver disease (NAFLD) rat models.
    Abbasi E, Goodarzi MT, Tayebinia H, Saidijam M, Khodadadi I.
    Metabol Open; 2021 Dec 01; 12():100140. PubMed ID: 34704009
    [Abstract] [Full Text] [Related]

  • 8. The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes.
    Haidari F, Zakerkish M, Borazjani F, Ahmadi Angali K, Amoochi Foroushani G.
    Trials; 2020 Jun 05; 21(1):483. PubMed ID: 32503652
    [Abstract] [Full Text] [Related]

  • 9. Dill-normalized liver lipid accumulation, oxidative stress, and low-density lipoprotein receptor levels in high cholesterol fed hamsters.
    Abbasi-Oshaghi E, Khodadadi I, Tavilani H, Mirzaei F, Goodarzi MT.
    ARYA Atheroscler; 2018 Sep 05; 14(5):218-224. PubMed ID: 30783412
    [Abstract] [Full Text] [Related]

  • 10. Suppressive impact of anethum graveolens consumption on biochemical risk factors of atherosclerosis in hypercholesterolemic rabbits.
    Setorki M, Rafieian-Kopaei M, Merikhi A, Heidarian E, Shahinfard N, Ansari R, Nasri H, Esmael N, Baradaran A.
    Int J Prev Med; 2013 Aug 05; 4(8):889-95. PubMed ID: 24049614
    [Abstract] [Full Text] [Related]

  • 11. Effect of dill tablet (Anethum graveolens L) on antioxidant status and biochemical factors on carbon tetrachloride-induced liver damage on rat.
    Oshaghi EA, Khodadadi I, Tavilani H, Goodarzi MT.
    Int J Appl Basic Med Res; 2016 Aug 05; 6(2):111-4. PubMed ID: 27127740
    [Abstract] [Full Text] [Related]

  • 12. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.
    Knipscheer HC, Nurmohamed MT, Van den Ende A, Plaat B, Pruijs HJ, Mulder WJ, Kastelein JJ.
    J Intern Med; 1994 Oct 05; 236(4):377-84. PubMed ID: 7931040
    [Abstract] [Full Text] [Related]

  • 13. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD, Balagtas CC, Rowan JP, Black DM.
    Atherosclerosis; 1996 Nov 15; 127(1):113-22. PubMed ID: 9006811
    [Abstract] [Full Text] [Related]

  • 14. The effect of 12 weeks Anethum graveolens (dill) on metabolic markers in patients with metabolic syndrome; a randomized double blind controlled trial.
    Mansouri M, Nayebi N, Keshtkar A, Hasani-Ranjbar S, Taheri E, Larijani B.
    Daru; 2012 Oct 04; 20(1):47. PubMed ID: 23351341
    [Abstract] [Full Text] [Related]

  • 15. The effect of a vaginal suppository formulation of dill (Anethum graveolens) in comparison to clotrimazole vaginal tablet on the treatment of vulvovaginal candidiasis.
    Saghafi N, Karjalian M, Ghazanfarpour M, Khorsand I, Rakhshandeh H, Mirteimouri M, Babakhanian M, Khadivzadeh T, Najafzadeh MJ, Ghorbani A, Pourali L, Bahman S.
    J Obstet Gynaecol; 2018 Oct 04; 38(7):985-988. PubMed ID: 29553834
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.
    Nestel P, Simons L, Barter P, Clifton P, Colquhoun D, Hamilton-Craig I, Sikaris K, Sullivan D.
    Atherosclerosis; 1997 Mar 21; 129(2):231-9. PubMed ID: 9105566
    [Abstract] [Full Text] [Related]

  • 17. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG, Papageorgiou AA, Avramidis MJ, Kontopoulos AG.
    Coron Artery Dis; 1995 Mar 21; 6(3):251-6. PubMed ID: 7788039
    [Abstract] [Full Text] [Related]

  • 18. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
    Guyton JR, Blazing MA, Hagar J, Kashyap ML, Knopp RH, McKenney JM, Nash DT, Nash SD.
    Arch Intern Med; 2000 Apr 24; 160(8):1177-84. PubMed ID: 10789612
    [Abstract] [Full Text] [Related]

  • 19. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.
    Zambón D, Ros E, Rodriguez-Villar C, Laguna JC, Vázquez M, Sanllehy C, Casals E, Sol JM, Hernández G.
    Metabolism; 1999 Jan 24; 48(1):47-54. PubMed ID: 9920144
    [Abstract] [Full Text] [Related]

  • 20. Effect of gemfibrozil in men with primary isolated low high-density lipoprotein cholesterol: a randomized, double-blind, placebo-controlled, crossover study.
    Miller M, Bachorik PS, McCrindle BW, Kwiterovich PO.
    Am J Med; 1993 Jan 24; 94(1):7-12. PubMed ID: 8420303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.